You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radical radiotherapy to pelvis

Showing 1 - 25 of 8,007
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Metastatic Trial in Ghent (radical prostatectomy, Whole pelvis radiotherapy)

Recruiting
  • Prostate Cancer Metastatic
  • radical prostatectomy
  • Whole pelvis radiotherapy
  • Ghent, Belgium
    University Hospital Ghent
Dec 16, 2022

Recurrent Prostate Cancer Trial in Bern (Ultrahypofractionated salvage radiotherapy to a local recurrence after radical

Recruiting
  • Recurrent Prostate Cancer
  • Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy
  • Androgen deprivation therapy
  • Bern, Switzerland
    Inselgruppe AG, Inselspital
Mar 1, 2023

Cervical Cancer, Uterine Cancer Trial (Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT))

Not yet recruiting
  • Cervical Cancer
  • Uterine Cancer
  • Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
  • (no location specified)
Feb 24, 2023

A Multicenter, Cross-sectional Study on Quality of Life in

Not yet recruiting
  • Assessing the Current Quality of Life Status of Esophageal Cancer Patients Who Have Undergone Radical Chemoradiotherapy/Radiotherapy and Long-term Survival
  • questionnaire investigation
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Apr 24, 2023

TPExtreme Induced Chemotherapy Followed by Surgery and

Recruiting
  • Oral Squamous Cell Carcinoma
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Modified radical surgery
  • Radical surgery
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
May 14, 2023

Neoadjuvant Chemo, PD-1 Antibody, Radiotherapy Trial (neoadjuvant chemo combined with PD-1 antibody + radical radiotherapy)

Not yet recruiting
  • Neoadjuvant Chemotherapy
  • +3 more
  • neoadjuvant chemotherapy combined with PD-1 antibody + radical radiotherapy
  • (no location specified)
Sep 21, 2022

Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

Active, not recruiting
  • Urinary Bladder Cancer
  • München, Germany
  • +2 more
Oct 19, 2022

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

Combined Postoperative Radiotherapy With Kidney Sparing Surgery

Recruiting
  • Locally Advanced
  • Urothelial Carcinoma Ureter
  • Radical surgery
  • Kidney sparing surgery+Postoperative radiotheray
  • Beijing, China
  • +1 more
Nov 2, 2023

Prostatic Tumor Trial in Rome (salvage SBRT)

Recruiting
  • Prostatic Neoplasm
  • salvage SBRT
  • Rome, Italy
    Regina Elena National Cancer Institute
Dec 19, 2022

Prostate Cancer Trial in Calgary, Kelowna, London (Conventionally-fractionated WPRT, Hypofractionated WPRT)

Active, not recruiting
  • Prostate Cancer
  • Conventionally-fractionated WPRT
  • Hypofractionated WPRT
  • Calgary, Alberta, Canada
  • +2 more
Apr 12, 2022

Prostate Cancer Trial in Cairo (Prostate Only Radiation, Prostate and Pelvic Lymph Node Radiation)

Recruiting
  • Prostate Cancer
  • Prostate Only Radiation
  • Prostate and Pelvic Lymph Node Radiation
  • Cairo, Egypt
    National Cancer Institute - Cairo University
Aug 9, 2022

Cervical Cancer Trial (Curcumin, Palliative radiotherapy)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Jul 14, 2023

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

Active, not recruiting
  • Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
  • +17 more
  • Gemcitabine Hydrochloride
  • Jacksonville, Florida
  • +3 more
Jul 5, 2022

Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Locally Advanced Hypopharyngeal Carcinoma
  • three cycles (toripalimab + cetuximab + platinum)
  • +2 more
  • Shanghai, Shanghai, China
    Eye & ENT Hospital of Fudan University
Nov 22, 2023

Prostate Cancer Trial in Dallas (Stereotactic Ablative Radiotherapy)

Active, not recruiting
  • Prostate Cancer
  • Stereotactic Ablative Radiotherapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 14, 2022

Cervical Cancer Trial in Prague (No adjuvant therapy, Adjuvant radiotherapy)

Recruiting
  • Cervical Cancer
  • No adjuvant therapy
  • Adjuvant radiotherapy
  • Prague, Czechia
    General University Hospital in Prague
Jul 25, 2022

Prostate Cancer, Physical Activity, Hypoxia Trial in Tromsø (Physical activity)

Terminated
  • Prostate Cancer
  • +2 more
  • Physical activity
  • Tromsø, Norway
    University Hospital of North Norway
Jan 5, 2023

Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)

Not yet recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Biopsy
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023

Merkel Cell Carcinoma Trial in United Kingdom (Radiotherapy, Surgery)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Radiotherapy
  • Surgery
  • Birmingham, United Kingdom
  • +13 more
Feb 14, 2022

Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)

Recruiting
  • Neoplasm Neck
  • docetaxel, cisplatin and 5-fluorouracil
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Uterine Cervical Tumors Trial in Hangzhou (Clean Intermittent Catheterization, Indwelling catheterization)

Completed
  • Uterine Cervical Neoplasms
  • Clean Intermittent Catheterization
  • Indwelling catheterization
  • Hangzhou, Zhejiang, China,, China
    Zhejiang Cancer Hospital
Jun 2, 2022

Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],

Recruiting
  • Urologic Cancer
  • Biochemical Recurrence of Malignant Neoplasm of Prostate
  • Pembrolizumab Injection [Keytruda]
  • Salvage Radiation Therapy (SRT)
  • Freiburg, Baden-Württemberg, Germany
    Clinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023